Clinical Trial Update: Efficacy of Probiotic ES1 for the Treatment of Non-Celiac Gluten Sensitivity [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy of probiotic ES1 for non-celiac gluten sensitivity. The status is unknown and no results are disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-celiac Gluten Sensitivity

Drugs mentioned

• Probiotic ES1

Snippet

Sponsor: Exzell Pharma Inc. | Conditions: Non-Celiac Gluten Sensitivity | Phase 2 | Status: UNKNOWN